Guidelines for preventing respiratory illness in older adults aged 60 years and above living in long-term care: A rapid review of clinical practice guidelines

Patricia Rios; Amruta Radhakrishnan; Sonia M. Thomas; Nazia Darvesh; Sharon E. Straus; Andrea C. Tricco

☐Methods by which the cost information was sought (e.g., a health economist was part of the guideline development panel, use of health technology assessments for specific drugs, etc.) NR ☐Information/description of the cost information that emerged from the inquiry (e.g., specific drug acquisition costs per treatment course) ☐How the information gathered was used to inform the guideline development process and/or formation of the recommendations 21. MONITORING/ AUDITING CRITERIA Provide monitoring and/or auditing criteria to measure the application of guideline recommendations. • Treatment for NHAP should take into account the individual's personal directives • There is a lack of well-designed studies in this patient population • Chest radiography is not widely available or practical in many locations • Microbiologic diagnosis of NHAP has significant limitations and as such, treatment of NHAP is usually empiric • Delay in administration of antibiotics for the empiric treatment of NHAP may lead to increased patient morbidity and mortality • Inappropriate use of antibiotics may adversely affect patient outcomes and may increase antimicrobial resistance Prevention